Investigational submicron diclofenac reduces use of opioid rescue medication in post-surgical pain in a Phase 3 study

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, has announced that the company's investigational, non-steroidal anti-inflammatory drug (NSAID) submicron diclofenac reduced the use of opioid rescue medication in patients with acute pain following bunionectomy surgery...
Pain / Anesthetics News From Medical News Today

Share:

Related Content